What are the recommended treatments to reduce menorrhagia (heavy menstrual bleeding)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Lightening Menstruation (Heavy Menstrual Bleeding)

For most women with heavy menstrual bleeding, start with the levonorgestrel-releasing intrauterine device (LNG-IUD 20 μg/day), which reduces menstrual blood loss by 71-95% and is the most effective medical therapy available. 1

First-Line Medical Options

The treatment hierarchy depends on your contraceptive needs and medical history:

Most Effective: Levonorgestrel IUD

  • The LNG-IUD (20 μg/day) is comparable in efficacy to endometrial ablation and is the only progestin IUD with proven effectiveness for heavy bleeding 1
  • Works primarily at the endometrial level with minimal systemic absorption
  • Provides dual benefit of contraception and bleeding reduction
  • A lower-dose device (14 μg/day) is available but lacks specific evidence for heavy bleeding 1

Alternative Medical Therapies

Tranexamic acid:

  • Reduces menstrual blood loss by approximately 53 mL per cycle compared to placebo 2
  • Effective in reducing bleeding volume and transfusion needs 3
  • Important contraindication: Avoid in women with cardiovascular disease (SCAD) due to thrombosis risk 1
  • Standard dosing: 5-7 days of treatment 4

Combined hormonal contraceptives (CHCs):

  • Significantly more effective than placebo for heavy bleeding 2
  • Contraindicated in women with cardiovascular disease or SCAD 1
  • Can be used as 10-20 days of treatment for acute bleeding 4

NSAIDs (mefenamic acid, naproxen):

  • Reduce menstrual blood loss but less effective than tranexamic acid 2
  • Use for 5-7 days during menstruation 4
  • Avoid in women with cardiovascular disease due to MI risk 1

Oral progestogens:

  • Cyclic oral progestin reduces bleeding by 87% 1
  • Often results in irregular bleeding with reduction to light flow
  • Can be used when estrogen-containing methods are contraindicated

Special Populations

Women on Antiplatelet Therapy (Post-SCAD)

This is a critical scenario where standard treatments are restricted:

  1. First reassess: Discontinue antiplatelet therapy if no longer indicated 1
  2. Preferred option: LNG-IUD (20 μg/day) - works locally with minimal systemic effects 1
  3. Avoid: NSAIDs, tranexamic acid, and combined hormonal contraceptives due to MI/thrombosis risk 1
  4. Alternative: Cyclic oral progestin (despite theoretical concerns) or consider endometrial ablation 1

Women on Anticoagulation

  • Progestin-only methods are preferred 5
  • GnRH agonists can be considered 5
  • Tranexamic acid can be used with same indications as non-anticoagulated patients 3

Acute Heavy Bleeding Requiring Urgent Intervention

Defined as bleeding saturating a large pad/tampon hourly for ≥4 hours 1:

  1. Assess hemodynamic stability (orthostatic vitals) 6
  2. Test for pregnancy in all reproductive-age women 1, 6
  3. Medical management first-line:
    • High-dose oral or injectable progestin-only medications for short-term control 1
    • Tranexamic acid (oral or IV) 3, 6
    • Multidose combined oral contraceptive regimen (if medically eligible) 5
  4. Reserve surgery for non-responders to medical therapy 6

When Medical Therapy Fails

Surgical options to consider:

  • Second-generation endometrial ablation (thermal balloon, microwave, radiofrequency) - more effective long-term than oral medical treatment 1
  • Hysterectomy for definitive management 7

Advantages of ablation:

  • Effective bleeding control
  • Reduces pregnancy risk
  • Avoids need for ongoing hormonal therapy 1

Critical Pitfalls to Avoid

  1. Do not use NSAIDs or tranexamic acid in women with cardiovascular disease - both increase MI and thrombosis risk 1
  2. Do not use combined hormonal contraceptives in women with SCAD or cardiovascular disease - relatively contraindicated 1
  3. Always exclude pregnancy before initiating treatment in reproductive-age women 1, 6
  4. Check for anemia (including ferritin) and underlying bleeding disorders, especially in adolescents 6
  5. Monitor hemoglobin and provide iron supplementation during menstrual flow in women on anticoagulation 8

Monitoring Heavy Menstrual Bleeding

  • Women should be taught to quantify bleeding (pad/tampon saturation) 8
  • Periodic hemoglobin monitoring in premenopausal women on anticoagulation 8
  • If bleeding persists despite treatment, investigate for underlying structural pathology 4

The evidence strongly supports the LNG-IUD as first-line therapy for most women, with treatment selection modified based on cardiovascular risk factors, anticoagulation status, and contraceptive needs.

References

Research

The medical management of abnormal uterine bleeding in reproductive-aged women.

American journal of obstetrics and gynecology, 2016

Related Questions

What is the appropriate management for a patient with acute heavy menstrual bleeding shortly after starting a NuvaRing, including tranexamic acid, NSAIDs, contraception counseling, anemia monitoring, and follow‑up recommendations?
Can non‑steroidal anti‑inflammatory drugs be used to treat heavy menstrual bleeding in a reproductive‑age woman without contraindications such as peptic ulcer disease, renal impairment, hypertension, NSAID‑induced asthma, or anticoagulant therapy?
What is the best method to stop and regulate prolonged menstrual bleeding in a 19-year-old woman who has been menstruating continuously for two months?
What are the recommended next steps for managing abnormal uterine bleeding in a woman who did not respond to medroxyprogesterone acetate (Provera)?
How should I evaluate and manage a 34-year-old woman presenting with heavy menstrual bleeding accompanied by dizziness and nausea?
Could you explain Alcohol Use Disorder and the therapeutic use of dissociative agents such as psilocybin and ketamine for my thesis?
What is the appropriate dosing regimen for mefenamic acid in adults and adolescents?
What is the appropriate emergency department intravenous antibiotic regimen for cellulitis in a 76-year-old male patient?
Is cefazolin (cefazolin) superior to ceftriaxone (Rocephin) for treating cellulitis in a 76-year-old man?
What is the definition of an epidermal inclusion cyst?
What is a validated bleeding assessment tool (BAT) and how is it used to assess bleeding risk?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.